Rose Therapeutics, Inc. — Form D
Rose Therapeutics, Inc. of NORRISTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-02. The offering totals $1.0M, of which $650K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-09-02
- Form: D
- Accession: 0001944189-22-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $650K
- Remaining: $350K
- Investors: 5
- Date of first sale: 2022-08-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-457875
Issuer
- Name: Rose Therapeutics, Inc.
- CIK: 0001944189
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 20 WEST MAIN STREET, 3RD FLOOR, NORRISTOWN, PA, 19401
- Phone: 917-453-2647
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Timothy Langloss | Director | Norristown, PA |
| Ira Sanders | Director | Oarland, NJ |
| Matthew Wotiz | Director | Norristown, PA |
| Timothy Langloss | Executive Officer | Norristown, PA |
| Matthew Wotiz | Executive Officer | Norristown, PA |
More